
General Cardiology
IE diagnosis, treatment, and surgical indications
Synthesized from 69 evidence-backed clinical questions linked to this topic — 4 supporting the intervention, 2 against the intervention.
The placed evidence leans toward benefit
4
Favor benefit
6% of all
2
Favor harm
3% of all
63 more (91%) still untested — not placed on the axis.
Insufficient certainty on 91% of questions
Does transcatheter aortic valve implantation (tavi) vs placebo improve outcomes in Prosthetic valve endocarditis?
Low Certainty+ Favors benefittranscatheter aortic valve implantation (tavi) vs placebo
13 studies (57,030 patients) provide low-certainty evidence for benefit of transcatheter aortic valve implantation (tavi) for the outcome in Prosthetic valve endocarditis.
Does bio-statin vs placebo improve outcomes in Infective endocarditis?
Low Certainty+ Favors benefitbio-statin vs placebo
3 studies (35,844 patients) provide low-certainty evidence for benefit of bio-statin for the outcome in Infective endocarditis.
Emerging evidence with 60 primary claims
Editorial commentary: Native mitral valve infective endocarditis—Surgical concerns?
Journal of Cardiac Surgery — Kahrovic A — Aug 2022
Mitral valve infective endocarditis: putting the puzzle pieces together†
European Journal of Cardio-Thoracic Surgery — Tomšič A — Feb 2018
Prosthetic valve endocarditis: what is the evidence for anticoagulant therapy?
Internal Medicine Journal — Yau J — Nov 2011
Acute mitral valve regurgitation secondary to papillary muscle rupture due to infective endocarditis
Journal of Cardiothoracic Surgery — Amirkhosravi F — Jul 2022
Mechanical valve replacement in children and teenagers
European Journal of Cardio-Thoracic Surgery — Antunes M — Jan 1989
Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.
Infective endocarditis (also known as IE, bacterial endocarditis, endocarditis). IE diagnosis, treatment, and surgical indications
As of 2026-09-11, the scientific consensus on Infective endocarditis is emerging. Emerging evidence with 60 primary claims Based on 60 analyzed claims across Synapse's enriched corpus, the evidence shows.
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/infective-endocarditis.
Deterministic synthesis from Synapse's enriched corpus — 55 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every Infective endocarditis paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search Infective endocarditis papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers